Navigation Links
Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
Date:1/16/2008

LEIDEN, The Netherlands, January 16 /PRNewswire/ -- Today Top Institute Pharma announces a highly promising research project that is aimed at the development of a malaria vaccine. This TI Pharma project will be an expansion of important findings from previous studies. The project aims to develop a highly protective malaria vaccine that would save the lives of millions of people in developing countries, especially infants and children. No malaria vaccine is currently commercially available, despite several decades of research. Multiple drugs have been developed to treat malaria infections. However, increasing numbers of both drug-resistant parasites and insecticide-resistant mosquitoes make the fight against malaria more and more difficult. As a result an efficacious vaccine is urgently needed. The United Nations recognizes this urgency and has made limiting malaria by 2015 a millennium goal.

The TI Pharma project has a budget of 16 million Euros ($US 23.6 million) over 4 years and will be carried out by a consortium that includes the American biotechnology company Sanaria Inc. of Rockville, Maryland, Radboud University Nijmegen Medical Centre and Leiden University Medical Center. Sanaria Inc. is exclusively dedicated to the production of a vaccine against malaria.

Malaria is one of the most prevalent infections in tropical and subtropical areas. The disease is caused by mosquito-transmitted protozoan parasites of the genus Plasmodium. Each year, malaria affects at least 300 million and kills at least 1 million people, principally in developing countries. Plasmodium falciparum infection produces the most lethal form of the disease and accounts for the majority of deaths.

Stephen Hoffman, CEO of Sanaria Inc. explains, "Humans are infected when malaria parasites are introduced by the bite of mosquitoes carrying these parasites. The illness results from the growth of the parasite in the blood. Sanaria's primary vaccine candidate is composed o
'/>"/>

SOURCE TI Pharma
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Advanced Energy Consortium will develop micro and nanosensors to boost energy production
2. Three Steps to Boost Asymchems Investment in China
3. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
4. New Scandinavian collaboration boosts nanotech development
5. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
6. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
7. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
8. Murad Boosts Skin Immunity With the New Murad(R) Professional Line
9. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
10. Kline Study: Better Brushing Habits Boost European Oral Care Sales
11. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...alif., Nov. 6 ,, 3...fer of Qutenza(TM) E.U. Marketing Authorization to...ogress in commercial readiness activities Expande...ctor, Marketing; and Director, Commercial Operatio...ctor and Audit Committee chairman , Upcomin...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Pers...s set to take place on February 22-24, 2010 in Phi...onference we will highlight key issues in forming ... their experiences. , Min...a for Arrowhead’s 2010 Personalized Medicin...
(Date:11/5/2009)...N.J., Nov. 5 DSM Pharmaceutical Pr...uring alliance with Galenix, Saint Jean D,Illac, F...scale manufacturing partner for Galenix commercial... will collaborate on business development opportun...ies, based on the strength of Galenix in drug prod...
(Date:11/5/2009)... Nov. 5 Transgenomic, In...ncial results for the quarter ended September 30, ...d in the tables that follow. ,, Third Quarter ...6,000 or $0.01 per share for the third quarter of ...1 per share for the third quarter of 2008. ,, ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...Pa., May 18 ViroPharma Incorporated (Nasdaq: VP...ional Organization for Rare Disorders (NORD) Annua...terase inhibitor (human)) to market for a rare and...E). , , HAE is a rare, severely debilitating, lif...ncy of C1 inhibitor, a human plasma protein. Patie...
...gazine Pays Tribute to America,s Top Research Scie...air of Prana,s Biotechnology Research & Develo...May 18 Dr. Rudy Tanzi, Prana Biotechnology,s (Nas...tor of the Genetics and Aging Research Unit at the...ses , will be featured in a six-page photo spread...
... Will be Reported from Phase 2 Studies Evaluating ...tal Cancer and Gastrointestinal Stromal Tumors (GI...ls, Inc. (Nasdaq: KERX ) today announced that fo...,s Akt-inhibitor for cancer, were accepted for pre...he 45th Annual Meeting of the American Society of ...
Other Biology Technology:ViroPharma Incorporated Honored by the National Organization for Rare Disorders 2ViroPharma Incorporated Honored by the National Organization for Rare Disorders 3ViroPharma Incorporated Honored by the National Organization for Rare Disorders 4ViroPharma Incorporated Honored by the National Organization for Rare Disorders 5ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 2ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 4
(Date:11/4/2009)...- Lowly bacteria, it turns out, hold the power to ... around the world clean up toxic waste on test sit...y RDX, were invented back in World War II and have...se high-energy compounds are often used to propel ...f TNT. , But with increased knowledge of their...
(Date:11/4/2009)....J., Oct. 20 Quest Diagn...ding provider of diagnostic testing, information a...ended September 30, 2009, income from continuing o...ed share, from $160 million, or $0.81 per diluted ...rd quarter results were reduced by a $0.03 per sha...
(Date:11/4/2009)...Calif., Oct. 23 GenVault Corporati...nagement for genomic discovery, medicine and ident...., GenVault,s President and CEO, will be presentin...n October 26th and 27th in La Jolla, CA. ,, Dur...verview of the company together with recent custom...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 1Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 2synergIT Presents at VMworld 2009 in San Francisco 58333 1synergIT Presents at VMworld 2009 in San Francisco 58333 2synergIT Presents at VMworld 2009 in San Francisco 58333 3RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2
...ve hair-like protrusions with a sticky protein on ...ed, bungee cord-like structure of the protrusions ...gh fluid flow inside the body, researchers report ...hers at the University of Washington in Seattle an... the bacterium E. coli attaches to mucous membrane...
...h shows that a chemical compound found in many air...ther deodorizing products, may be harmful to the l...titute of Environmental Health Sciences (NIEHS), a...that exposure to a volatile organic compound (VOC)...odest reductions in lung function. , "Even a small...
... microorganisms manage to exist and even thrive in...ot springs? A team of scientists from the Weizmann...f. Avigdor Scherz, has found that a switch in just...can make a difference between functioning best at ...in extreme heat. The results of their research, wh...
Other Biology News:Tiny shock absorbers help bacteria stick around inside the body 2Chemical in many air fresheners may reduce lung function 2Chemical in many air fresheners may reduce lung function 3Bacteria beat the heat 2
...nal [6331] to Salmonella typhimurium The genus Sa...eae. The genus is composed of Gram-negative bacill...Salmonellae possess 3 major antigens; the "H" or f... antigen (part of the LPS moiety) and the "Vi" or ...
...W4 liquid handling system from Molecular Devices p...l in one instrument. The system handles a variety ...6-, 384- and 1536-welland is the first to handle 1...optimized to dispense from four different channels...
...sodium pyruvate, 50 mg/L streptomycin sulfate, 100...lcium chloride, and magnesium chloride. The use of...is generally attributed to early workers in the fi...f inorganic salts designed to maintain contractili...
Horizontal Laminar Flow Work Station from Terra Universal, Inc.
Biology Products: